BNTX logo

BIONTECH SE-ADR

BNTXNASDAQ
🏆 #378 by market capEarnings Nov 3Biotech
$92.80▲ $0.00 (+0.00%)
🌙 After hours$92.80▲ 0.00%Regular close · extended-hours price shown
1h—
24h▲ 0.0%
7d▲ 0.7%
14d▼ 0.2%
30d▲ 3.0%
1y▼ 16.4%
🏦Market Cap
$23.47B
Mid Cap
📈Revenue Growth (YoY)
-11.8%
Declining
📊Gross Margin
79.2%
High
💵FCF Margin
41.7%
Strong
⚖️P/S Ratio
7.6x
Fair
Otter Score
47
Weak
📊

Analyst Ratings

Price
$92.80
Total
24
Raised
4
Lowered
0
Avg PT
$130.43
H / L
$155 / $96
InstitutionActionRatingDate
Citigroup
ReiteratedBuy2026-08-05
Evercore ISI Group
ReiteratedOutperform2026-08-05
Morgan Stanley
ReiteratedOverweight2026-07-08
UBS
UpgradedNeutral → Buy2026-05-27
Wells Fargo
ReiteratedOverweight2026-05-06
Canaccord Genuity
ReiteratedBuy2026-05-06
HC Wainwright & Co.
ReiteratedBuy2026-04-27
TD Cowen
ReiteratedHold2026-03-11
BMO Capital
ReiteratedOutperform2026-03-11
Jefferies
ReiteratedBuy2026-03-10
Goldman Sachs
UpgradedNeutral → Buy2026-01-16
JP Morgan
ReiteratedNeutral2025-10-23
B of A Securities
ReiteratedBuy2025-08-05
Truist Securities
ReiteratedBuy2025-06-03
HSBC
ReiteratedBuy2024-10-07
Deutsche Bank
ReiteratedBuy2024-09-19
HC Wainwright& Co.
ReiteratedBuy2024-01-23
Redburn Partners
UpgradedNeutral → Buy2023-05-17
SVB Leerink
ReiteratedOutperform2022-07-29
Bryan Garnier
UpgradedNeutral → Buy2021-08-11
H.C. Wainwright
ReiteratedNeutral2020-04-13
Wolfe Research
ReiteratedOutperform2019-11-05
Bank of America
ReiteratedBuy2019-11-04
Berenberg
ReiteratedBuy2019-11-04
One row per institution, most recent rating